MedPath

Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients

Not Applicable
Completed
Conditions
Asthma
Interventions
Behavioral: Electronic sensor and OW education
Registration Number
NCT02913092
Lead Sponsor
Montefiore Medical Center
Brief Summary

This study will evaluate the role of using electronic sensors for asthma inhaler devices in monitoring medication adherence and asthma control

Detailed Description

This study will assess the feasibility of using electronic sensors for asthma inhalers in a population of urban minority adults and children with moderate-severe asthma in the Bronx.

Investigators will also assess differences in asthma outcomes (specifically asthma control as a primary outcome measure) and treatment adherence in a group of participants with moderate-severe asthma who use inhalers with electronic sensors and real-time remote outreach worker monitoring/feedback compared to a group of participants who use inhalers with electronic sensors but without real-time monitoring/feedback.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
81
Inclusion Criteria
  • Adults (>18 years) and children (5-11 years old) with a clinical history (i.e. physician-diagnosed) of asthma
  • Moderate to severe asthmatics with ≥1 asthma-related ED visits or hospitalizations in the past year
  • Use of daily controller inhaler medications
  • Adult non-smokers, or lifetime use <5 pack years with no smoking in last 1 yr
  • Smartphone required
  • English or Spanish speaking
Exclusion Criteria
  • No smartphone
  • Use of oral corticosteroids in prior 4 weeks
  • Pregnancy
  • Psychiatric conditions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Electronic sensor and OW educationElectronic sensor and OW educationMDI sensor-generated alerts will be relayed and responded to (e.g. outreach worker contacts the participant for a missed dose) in real-time to the intervention group. Outreach worker will also assess intervention group participants' need for further asthma education and provide asthma education over the phone
Primary Outcome Measures
NameTimeMethod
Asthma Control Testchange from baseline to 6 months

validated asthma control measure

Secondary Outcome Measures
NameTimeMethod
Medication adherencechange from baseline to 6 months

measured by electronic sensor

Health care utilizationchange from baseline to 6 months

ED visits and hospitalizations will be assessed via electronic health records

Trial Locations

Locations (1)

Montefiore Medical Center

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath